Tauroursodeoxycholic Acid Attenuates Diet-Induced and Age-Related Peripheral Endoplasmic Reticulum Stress and Cerebral Amyloid Pathology in a Mouse Model of Alzheimer's Disease.

Abstract

BACKGROUND:

Obesity and diabetes are well-established risk factors of Alzheimer's disease (AD). In the brains of patients with AD and model mice, diabetes-related factors have been implicated in the pathological changes of AD. However, the molecular mechanistic link between the peripheral metabolic state and AD pathophysiology have remained elusive. Endoplasmic reticulum (ER) stress is known as one of the major contributors to the metabolic abnormalities in obesity and diabetes. Interventions aimed at reducing ER stress have been shown to improve the systemic metabolic abnormalities, although their effects on the AD pathology have not been extensively studied.

OBJECTIVES:

We examined whether interventions targeting ER stress attenuate the obesity/diabetes-induced Aβ accumulation in brains. We also aimed to determine whether ER stress that took place in the peripheral tissues or central nervous system was more important in the Aβ neuropathology. Furthermore, we explored if age-related metabolic abnormalities and Aβ accumulation could be suppressed by reducing ER stress.

METHODS:

APP transgenic mice (A7-Tg), which exhibit Aβ accumulation in the brain, were used as a model of AD to analyze parameters of peripheral metabolic state, ER stress, and Aβ pathology in the brain. Intraperitoneal or intracerebroventricular administration of taurodeoxycholic acid (TUDCA), a chemical chaperone, was performed in high-fat diet (HFD)-fed A7-Tg mice for ~1 month, followed by analyses at 9 months of age. Mice fed a normal diet were treated with TUDCA by drinking water for 4 months and intraperitoneally for 1 month in parallel, and analyzed at 15 months of age.

RESULTS:

Intraperitoneal administration of TUDCA suppressed ER stress in the peripheral tissues and ameliorated the HFD-induced obesity and insulin resistance. Concomitantly, Aβ levels in the brain were significantly reduced. In contrast, intracerebroventricular administration of TUDCA had no effect on the Aβ levels. Peripheral administration of TUDCA was also effective against the age-related obesity and insulin resistance, and markedly reduced amyloid accumulation.

CONCLUSIONS:

Interventions that target peripheral ER stress might be beneficial therapeutic and prevention strategies against brain Aβ pathology associated with metabolic overload and aging.

• Authors: T Ochiai, T Nagayama, K Matsui, K Amano, T Sano, T Wakabayashi, T Iwatsubo
• Journal: The journal of prevention of Alzheimer's disease (J Prev Alzheimers Dis) Vol. 8 Issue 4 Pg. 483-494 ( 2021) ISSN: 2426-0266 [Electronic] Switzerland
• PMID: 34585224 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Amyloid beta-Peptides
• Antiviral Agents
• Taurochenodeoxycholic Acid
• ursodoxicoltaurine

Topics

• Alzheimer Disease (drug therapy, metabolism, prevention & control)
• Amyloid beta-Peptides (metabolism)
• Animals
• Antiviral Agents (administration & dosage, pharmacology)
• Brain (metabolism)
• Diet
• Disease Models, Animal
• Endoplasmic Reticulum Stress (drug effects)
• Humans
• Infusions, Intraventricular
• Injections, Intraperitoneal
• Mice
• Mice, Transgenic
• Taurochenodeoxycholic Acid (administration & dosage, pharmacology)